Management of Miscarriage Bleeding

Clinical Context and Management

The World Health Organization strongly recommends early tranexamic acid (within 3 hours of delivery) for clinically diagnosed postpartum hemorrhage, defined as >500 mL blood loss after vaginal delivery or >1000 mL after cesarean, or any bleeding compromising hemodynamic stability 1, 2
Oxytocin is the standard first-line agent for controlling bleeding after delivery or surgical evacuation of pregnancy loss, with dosing recommendations including 10 units oxytocin added to 500 mL physiologic saline, infused at 20-40 drops/minute 1, 2
The American College of Obstetricians and Gynecologists recommends a comprehensive hemorrhage protocol, including fluid replacement with crystalloids, monitoring of vital signs and urine output, laboratory assessment, and non-surgical interventions such as bimanual compression and intrauterine balloon tamponade 2, 4, 5

The American Society of Anesthesiologists recommends transfusion thresholds, including red cells for Hb <70 g/L or hemodynamic instability, and fibrinogen replacement targeting ≥1.5 g/L for 3 days 5
The International Society on Thrombosis and Haemostasis recommends point-of-care testing (TEG/ROTEM) over laboratory testing due to speed 5

The Royal College of Obstetricians and Gynaecologists recommends risk stratification for thrombotic risk factors before choosing management approach, including prior VTE, family history of VTE, and known thrombophilia 6
Surgical management of miscarriage warrants thromboprophylaxis assessment, with LMWH prophylaxis for 7-10 days if surgical procedure performed with additional risk factors 6
The American College of Obstetricians and Gynecologists recommends fibrinogen replacement targeting ≥1.5 g/L for 3 days in women with bleeding disorders (afibrinogenemia, severe hypofibrinogenemia) 3

Delaying tranexamic acid administration beyond 3 hours post-delivery is suspected to be harmful, with effectiveness dropping 10% every 15 minutes 2, 4
Giving tranexamic acid beyond 3 hours post-delivery is suspected to be harmful 2, 4
Overlooking fibrinogen levels, with hypofibrinogenemia (<2-3 g/L) predicting progression to major obstetric hemorrhage 5